vs
Molecular weight
3367.97 g/mol
711.85 g/mol
Half-life
~30 min (no DAC / Mod GRF 1-29) / ~8 days (with DAC)
~2 hours
Research areas
Growth hormone optimizationBody compositionRecovery and repairAnti-agingIGF-1 elevationSleep quality
Growth hormone optimizationBody compositionSleep qualityRecoveryPostoperative ileusAnti-emetic effectsBone density
Typical dosing
100–300 mcg · 1-3x daily (no DAC) / 2x weekly (DAC) · 8-12 weeks
200–300 mcg · 1-3x daily · 8-12 weeks
FDA status
Not FDA-approved. Category 2 (under evaluation for 503A compounding)
Not FDA-approved. Category 2 (under evaluation for 503A compounding)
WADA status
Prohibited (S2 — peptide hormones, growth factors, and related substances)
Prohibited (S2 — peptide hormones, growth factors, and related substances)
